Order results by:
| Issue | Title | |
| Vol 11, No 1 (2019) | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Abstract similar documents |
| B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... -tau. The study of CSF biomarkers opens up prospects not only for the detection of iNPH, but also ..." | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| "... for the diagnosis and treatment of cognitive impairment (CI). First and foremost, biomarker testing is indicated ..." | ||
| Vol 14, No 2 (2022) | New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. | Abstract similar documents |
| A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak | ||
| "... . Correlations of different strength between the values of biomarkers in blood plasma and CSF and the results ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... , detection of biological markers (biomarkers) of AD in the cerebrospinal fluid (CSF) is of great importance ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... as the cause of MCI, biological markers in the cerebrospinal fluid (CSF) can be used, such as low Aβ42 levels ..." | ||
| Vol 14, No 4 (2022) | The role of oxidative stress in the development of Alzheimer's disease | Abstract similar documents |
| V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya | ||
| "... -amyloid plaques and neurofibrillary tau-glomeruli in the development of AD. We analyzed the role ..." | ||
| Vol 5, No 4 (2013) | Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments | Abstract similar documents |
| Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova | ||
| "... ) and the specific features of their transformation to dementia. Cerebrospinal fluid (CSF) was investigated in 60 ..." | ||
| Vol 11, No 3 (2019) | he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments | Abstract similar documents |
| I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova, K. M. Naumov, I. A. Lupanov, G. A. Kilivaeva, M. R. Alizade | ||
| "... plaques and tau tangles in a patient with clinical signs of dementia. Over the following 100 years ..." | ||
| Vol 11, No 1 (2019) | Primary progressive aphasia | Abstract PDF (Eng) similar documents |
| V. A. Mikhailov, Yu. V. Kotsiubinskaya, N. Yu. Safonova, N. I. Ananieva, I. K. Stulov | ||
| Vol 16, No 3 (2024) | Concentration of immunoglobulin free light chains in cerebrospinal fluid in the diagnosis of multiple sclerosis | Abstract PDF (Eng) similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... in the CSF of MS patients. This biomarker showed a high specificity for this pathology. However, further ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... progressive MS (PPMS and SPMS, respectively). Currently, there is an active search for MS biomarkers capable ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... Cerebrospinal fluid (CSF), which bathes the entire central nervous system and is often in direct ..." | ||
| Vol 15, No 2 (2023) | Readiness potential as a neurophysiological marker of functional movement disorders | Abstract PDF (Eng) similar documents |
| V. A. Tolmacheva, E. N. Dudnik, R. M. Shishorin, D. S. Petelin, V. E. Bezrukov, A. N. Gamirova, Yu. V. Dolgopolova, B. A. Volel | ||
| Vol 15, No 5 (2023) | The role of cellular immunity and systemic inflammation indices in the pathogenetic mechanisms of mental disorders | Abstract similar documents |
| A. P. Gorbunova, G. V. Rukavishnikov, E. D. Kasyanov, G. E. Mazo | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... Studies of the biomarkers of atrial cardiopathy seem to be promising for identifying patients ..." | ||
| Vol 13, No 2 (2021) | Possibilities of using laboratory biomarkers for the objective diagnosis of depressive disorders | Abstract similar documents |
| V. K. Shamrey, E. S. Kurasov, Ya. S. Zobin, N. V. Tsygan | ||
| "... Objective: to assess the possibility of using laboratory biomarkers to objectify ..." | ||
| Vol 13, No 3 (2021) | Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults | Abstract similar documents |
| T. N. Pushkar, A. M. Azhigova, P. N. Vlasov, A. B. Kozhokaru | ||
| Vol 14, No 4 (2022) | Structural and functional biomarkers of the effect of navigational repetitive transcranial magnetic stimulation in patients with drug-resistant depression | Abstract similar documents |
| A. G. Poydasheva, D. O. Sinitsyn, I. S. Bakulin, N. A. Suponeva, M. A. Piradov | ||
| "... the relevance of the search for predictive biomarkers of the effect. Objective: to search for neuroimaging ..." | ||
| Vol 15, No 3 (2023) | Inflammatory biomarkers and growth factors in patients with chronic cerebrovascular disease after coronavirus infection | Abstract similar documents |
| E. B. Kuznetsova, O. N. Voskresenskaya, N. B. Zakharova, N. S. Kuznetsov | ||
| "... Objective: to study the level of inflammatory biomarkers and growth factors in the peripheral ..." | ||
| Vol 14, No 1 (2022) | Biological basis of aggressive behavior | Abstract similar documents |
| O. A. Makushkina, O. I. Gurina, V. A. Golenkova | ||
| "... . The relevance of evaluating the biomarkers of public danger is substantiated. Finally, questions ..." | ||
| Vol 13, No 5 (2021) | Biological basis of aggressive behavior | Abstract similar documents |
| O. A. Makushkina, O. I. Gurina, V. A. Golenkova | ||
| Vol 11, No 2 (2019) | Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease | Abstract similar documents |
| A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko | ||
| Vol 10, No 1 (2018) | Vascular myelopathy: causes and mechanisms, possibilities of diagnosis and treatment | Abstract similar documents |
| G. V. Ponomarev, A. A. Skoromets, V. S. Krasnov, O. V. Rodionova, D. D. Glistenkova, N. F. Porkhun, S. A. Dambinova | ||
| Vol 10, No 4 (2018) | The brain’sglymphatic system:physiological anatomy and clinical perspectives | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, N. N. Yakhno, E. A. Orlov, E. E. Porubayeva, E. Yu. Popova | ||
| "... fluid and soluble compounds from the central nervous system into cerebrospinal fluid (CSF), which ..." | ||
| Vol 16, No 2 (2024) | Laboratory indicators of hemostasis, lipid metabolism and endothelial dysfunction in men aged 18–50 years with different subtypes of ischemic stroke | Abstract similar documents |
| N. A. Pizov, N. S. Baranova | ||
| Vol 16, No 6 (2024) | Evaluation of the content of microbial metabolites in cerebrospinal fluid of individuals with radiologically isolated syndrome | Abstract similar documents |
| M. A. Omarova, O. G. Zhilenkova, A. N. Boyko | ||
| "... , such as cerebrospinal fluid (CSF). In our previous studies, we have already analyzed the CSF in different variants of MS ..." | ||
| Vol 17, No 2 (2025) | Differences in cerebrospinal fluid microRNA profiles in patients with remitting multiple sclerosis and patients with other neurological diseases | Abstract similar documents |
| М. А. Omarova, М. S. Kozin, А. N. Boyko | ||
| "... Objective: to compare microRNA profiles in cerebrospinal fluid (CSF) of patients with remitting ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Microbiota markers level in the cerebrospinal fluid of patients with multiple sclerosis and radiologically isolated syndrome | Abstract similar documents |
| A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii | ||
| "... on microbiota markers in the cerebrospinal fluid (CSF) of patients with MS and predisposing conditions ..." | ||
| Vol 16 (2024): (Suppl. 2) | Combined analysis of free kappa chains and central vein sign increases the specificity of multiple sclerosis diagnosis | Abstract similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... vein sign (CVS) and the concentration of free kappa chains (FKC) in cerebrospinal fluid (CSF ..." | ||
| Vol 17, No 3 (2025) | Structure of the subarachnoid lymphatic-like membrane as a meningeal selective barrier and immunological regulator | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, K. I. Urazmetova, N. A. Rizaeva, M. V. Sankova, А. V. Moiseeva, A. A. Moiseenko, A. A. Belichenko, A. T. Nikitina, L. A. Gridin | ||
| "... the subarachnoid space. It performs critical functions including immune cell regulation, cerebrospinal fluid (CSF ..." | ||
| Vol 17, No 1 (2025) | Subjective and functional cognitive impairment: diagnostics using biological markers of Alzheimer's disease | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Zakharov, K. V. Shevtsova, Ya. I. Chervyakova | ||
| "... ) at the SCI stage using biological markers for AD in cerebrospinal fluid (CSF). The article presents ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | The role of neuroinflammation in the pathogenesis of epilepsy | Abstract similar documents |
| L. V. Lipatova, N. B. Serebryanaya, N. A. Sivakova | ||
| "... ) and controlled epilepsy (n = 80)) and 30 apparently healthy donors. The blood and cerebrospinal fluid (CSF ..." | ||
| Vol 9, No 4 (2017) | Current approaches to diagnosing and treating major neurocognitive disorder | Abstract similar documents |
| A. A. Kulesh, V. V. Shestakov | ||
| "... tomography, and estimation of cerebrospinal fluid β-amyloid and tau protein levels find increasing ..." | ||
| Vol 16, No 2 (2024) | Alzheimer's disease: diagnosis and treatment, errors in patient management | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina | ||
| "... reflect the pathological formation of beta-amyloid and tau protein in the brain. Magnetic resonance ..." | ||
| Vol 11, No 3 (2019) | Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? | Abstract similar documents |
| G. R. Tabeeva, E. A. Kirjanova | ||
| "... manifestations, neuromorphological changes, as well as genetic and neuroimaging biomarkers. The complex ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... detected, in some patients – blood and cerebrospinal fluid (CSF) polymerase chain reaction, serum and CSF ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment | Abstract similar documents |
| I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... , by taking into account the biomarkers of amyloidosis, tauopathy, neurodegeneration, and cerebrovascular ..." | ||
| Vol 8, No 4 (2016) | ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT | Abstract similar documents |
| A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... in the brain structures, and from those of an analysis of biomarkers in the cerebrospinal fluid ..." | ||
| Vol 11, No 3 (2019) | Role of cerebral reserve assessed using diffusion-weighted magnetic resonance imaging in determining the rehabilitation potential of acute ischemic stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, V. E. Drobakha, K. V. Sobyanin, S. P. Kulikova, A. Yu. Bykova, N. A. Kaileva, A. A. Monak, I. N. Shardakov, V. V. Shestakov | ||
| "... ) is considered as a promising biomarker in ischemic stroke (IS). The basis of this study is the assumption ..." | ||
| Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
| A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
| "... to identify and implement a biomarker, which should then be implemented in routine clinical practice. ..." | ||
| Vol 14, No 2 (2022) | Muscular factor in the development of musculoskeletal pain. Treatment options | Abstract similar documents |
| A. I. Isaikin, T. I. Nasonova | ||
| "... (such as biomarkers, electrophysiological evaluation, imaging, diagnostic blocks, etc.) for objectifying ..." | ||
| Vol 12, No 5 (2020) | Anti-inflammatory and anti-aging effects of chondroitin sulfate | Abstract similar documents |
| O. A. Shavlovskaya, I. A. Zolotovskaya, Yu. S. Prokofyeva | ||
| "... in their structure and function. Studying the individual biomarkers of ageing is regarded as the most plausible ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... revealed biomarkers of AD, which enabled a diagnosis of late-onset AD at the predementia stage. The paper ..." | ||
| Vol 17, No 3 (2025) | Structural and functional brain changes in body dysmorphic disorder according to neuroimaging data | Abstract similar documents |
| V. E. Medvedev | ||
| "... neuroimaging results as potential prognostic biomarkers for treatment efficacy and disease outcomes. ..." | ||
| Vol 13, No 4 (2021) | Oral administration of cyanocobalamin for functional vitamin В12 deficiency: efficacy and safety | Abstract similar documents |
| E. V. Shikh, Zh. M. Sizova, M. O. Astaeva | ||
| "... administration. The use of functional vitamin В12 deficiency biomarkers, such as vitamin В12 levels ..." | ||
| Vol 10, No 3 (2018) | MicroRNA expression profile in patients in the early stages of ischemic stroke | Abstract similar documents |
| I. S. Zhanin, V. A. Gusar, A. T. Timofeeva, V. G. Pinelis, A. Yu. Asanov | ||
| "... once from those of the controls. Results. A list of 45 miRNAs, that might be potential biomarkers ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... of inflammatory biomarkers, including interleukins (IL): IL6, IL1, as well as galectin-3, as a link between COVID ..." | ||
| 1 - 47 of 47 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
